独立行政法人労働者健康安全機構 関西労災病院は、兵庫県尼崎市にある医療機関。独立行政法人労働者健康安全機構が運営する病院である。労災病院として出発し、その後の診療体制の拡充等により尼崎市周辺の地域医療の中核を担うようになっている。

During the past decade, Kansai Rosai Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kansai Rosai Hospital" #1 sponsor was "Boston Scientific Corporation" with 6 trials, followed by "Haruhiko Fukuda" with 2 trials sponsored, "Takeda" with 2 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored and "C. R. Bard" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kansai Rosai Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Kansai Rosai Hospital" are "Colorectal Cancer" (3 trials), "Fallopian Tube Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Peripheral Arterial Disease" (2 trials) and "Primary Peritoneal Cancer" (2 trials). Many other conditions were trialed in "Kansai Rosai Hospital" in a lesser frequency.

Most popular intervention types in "Kansai Rosai Hospital" are "Device" (11 trials), "Drug" (9 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Jetstream Atherectomy System" (2 trials), "Niraparib" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "5FU+l-leucovorin" (1 trials) and "Aprepitant / Fosaprepitant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kansai Rosai Hospital" are 17 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Kansai Rosai Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Kansai Rosai Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kansai Rosai Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".